A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects
Crossref DOI link: https://doi.org/10.1007/s00228-017-2282-7
Published Online: 2017-06-21
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Juif, Pierre-Eric
Boehler, Margaux
Donazzolo, Yves
Bruderer, Shirin
Dingemanse, Jasper
License valid from 2017-06-21